Dan Dearborn - 06 Jan 2026 Form 4 Insider Report for TuHURA Biosciences, Inc./NV (HURA)

Role: Chief Financial Officer
Signature: /s/ Dan Dearborn
Issuer symbol: HURA
Transactions as of: 06 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 08 Jan 2026, 16:35:21 UTC
Previous filing: 17 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dearborn Dan	Chief Financial Officer	10500 UNIVERSITY CENTER DRIVE, SUITE 110, TAMPA	/s/ Dan Dearborn	08 Jan 2026	0001975443

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HURA	Options (Right to Buy)	Award	$0	+273,696		$0.000000	273,696	06 Jan 2026	Common Stock	273,696	$0.7300	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a supplemental option grant to the option grant previously made in December 2025. One-third of the stock options become exercisable on the first, second, and third anniversary of January 6, 2025.